Andlauer Healthcare Group Inc. (TSE:AND) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Andlauer Healthcare Group Inc. (TSE:ANDGet Free Report) have been given an average rating of “Moderate Buy” by the seven research firms that are currently covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is C$49.43.

Several brokerages have issued reports on AND. National Bankshares lifted their price target on Andlauer Healthcare Group from C$46.00 to C$47.00 and gave the stock a “sector perform” rating in a research note on Thursday, March 7th. Stifel Nicolaus cut their target price on Andlauer Healthcare Group from C$55.00 to C$52.00 and set a “buy” rating for the company in a research note on Monday, May 6th. Eight Capital decreased their price target on shares of Andlauer Healthcare Group from C$62.00 to C$58.00 and set a “buy” rating on the stock in a research note on Thursday, March 7th. CIBC cut their price objective on shares of Andlauer Healthcare Group from C$52.00 to C$50.00 and set an “outperform” rating for the company in a research note on Monday, May 6th. Finally, Royal Bank of Canada reduced their target price on shares of Andlauer Healthcare Group from C$43.00 to C$41.00 and set a “sector perform” rating on the stock in a report on Monday, May 6th.

Get Our Latest Stock Analysis on AND

Insider Buying and Selling at Andlauer Healthcare Group

In other news, Director Ronald Martin Skelton sold 1,500 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. The stock was sold at an average price of C$40.87, for a total transaction of C$61,309.95. Corporate insiders own 1.43% of the company’s stock.

Andlauer Healthcare Group Trading Up 1.4 %

Shares of Andlauer Healthcare Group stock opened at C$38.63 on Friday. The company has a debt-to-equity ratio of 26.06, a current ratio of 1.94 and a quick ratio of 1.66. Andlauer Healthcare Group has a 1 year low of C$36.43 and a 1 year high of C$45.67. The firm has a market cap of C$752.51 million, a PE ratio of 25.58 and a beta of 0.69. The company has a 50 day simple moving average of C$39.62 and a two-hundred day simple moving average of C$40.46.

Andlauer Healthcare Group (TSE:ANDGet Free Report) last posted its quarterly earnings data on Thursday, May 2nd. The company reported C$0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C$0.53 by C($0.18). Andlauer Healthcare Group had a return on equity of 13.82% and a net margin of 10.02%. The company had revenue of C$161.14 million for the quarter, compared to the consensus estimate of C$168.50 million. Analysts expect that Andlauer Healthcare Group will post 1.6396243 earnings per share for the current fiscal year.

Andlauer Healthcare Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 15th will be issued a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date of this dividend is Friday, June 28th. Andlauer Healthcare Group’s dividend payout ratio (DPR) is presently 23.84%.

Andlauer Healthcare Group Company Profile

(Get Free Report

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Featured Stories

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.